Temelimab
Temelimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Temelimab is under investigation in clinical trial NCT02782858 (Clinical Trial Assessing the HERV-W Env Antagonist Gnbac1 for Efficacy in MS).
| Trade Name | Temelimab |
| Generic | Temelimab |
| Temelimab Other Names | Temelimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Temelimab
